ROSE ERIC A MD 4
4 · Orchestra BioMed Holdings, Inc. · Filed May 19, 2023
Insider Transaction Report
Form 4
ROSE ERIC A MD
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001 per share ("Common Stock")
2023-05-17$1.08/sh+2,325$2,511→ 2,325 total - Tax Payment
Common Stock
2023-05-17$16.04/sh−157$2,518→ 2,168 total - Exercise/Conversion
Warrant (Right to Buy)
2023-05-17−2,325→ 0 totalExercise: $1.08From: 2023-01-26Exp: 2023-05-31→ Common Stock (2,325 underlying)
Footnotes (3)
- [F1]On May 17, 2023, the Reporting Person exercised a warrant to purchase 2,325 shares of Common Stock at an exercise price $1.08 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Orchestra BioMed Holdings, Inc. (the "Issuer") withholding 157 of the warrant shares to pay the exercise price and issuing the Reporting Person the remaining 2,168 shares of Common Stock.
- [F2]Represents the shares of Common Stock deemed withheld by the Issuer in connection with the cashless exercise.
- [F3]Pursuant to Section 3(c) of the warrant, the price was calculated as the average closing price per share of Common Stock for the 20 trading days immediately preceding the date on which the notice of exercise was deemed to have been sent to the Issuer.